Sodium arachidonate induced in vitro polymorphonuclear leukocyte aggregation.

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Human polymorphonuclear leukocytes (PMNs) play crucial roles in inflammatory responses.
• Arachidonic acid (AA) is a key fatty acid involved in cellular signaling and inflammation.

Purpose of the Study:

• To investigate the mechanism of PMN aggregation induced by sodium arachidonate (AA).
• To elucidate the role of cyclooxygenase and lipoxygenase pathways in AA-induced PMN aggregation and lactate dehydrogenase (LDH) release.

Main Methods:

• Dose-dependent aggregation assays using human PMNs and sodium arachidonate.
• Assessment of lactate dehydrogenase (LDH) release as a marker of cell integrity.
• Electron microscopy to visualize morphologic changes in aggregated PMNs.
• Pharmacological modulation using indomethacin (cyclooxygenase inhibitor) and 1-methylimidazole (lipoxygenase inhibitor).
• Investigation of cytochalasin B (CTB) effects on aggregation and LDH release.

Main Results:

• Sodium arachidonate induced dose-dependent PMN aggregation, unlike epinephrine or ADP.
• PMNs released LDH during AA-induced aggregation, with observed morphologic changes.
• Indomethacin enhanced AA-induced aggregation, while 1-methylimidazole inhibited it and LDH release.
• Cytochalasin B did not affect AA-induced aggregation or LDH release, nor did it alter the effects of indomethacin or 1-methylimidazole.

Conclusions:

• Lactate dehydrogenase (LDH) release is intrinsically linked to the PMN aggregation process induced by AA.
• A competitive interaction exists between cyclooxygenase and lipoxygenase pathways in regulating PMN aggregation.
• Shifting this balance towards lipoxygenase activity potentiates PMN aggregation.